Novavax (NVAX) Debt to Equity (2010 - 2015)

Novavax's Debt to Equity history runs 6 years deep, the most recent figure standing at $0.0 for Q3 2015.

• In Q3 2015, Debt to Equity changed N/A year-over-year to $0.0; the TTM figure through Sep 2015 stood at $0.0 (changed N/A YoY), while the FY2014 annual figure was $0.0, down 65.18% from the prior year.
• Debt to Equity was $0.0 for Q3 2015 at Novavax, down from $0.0 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.03 in Q3 2012 to a low of $0.0 in Q3 2015.
• Historically, Debt to Equity has averaged $0.01 across 5 years, with a median of $0.01 in 2011.
• The sharpest annual moves came in 2012 and 2015: Debt to Equity surged 363.16% in 2012, then sank 86.01% in 2015.
• A 5-year view of Debt to Equity shows it stood at $0.01 in 2011, then soared by 128.17% to $0.01 in 2012, then tumbled by 61.14% to $0.0 in 2013, then plunged by 65.18% to $0.0 in 2014, then sank by 92.87% to $0.0 in 2015.
• The last three Debt to Equity figures came in at $0.0 (Q3 2015), $0.0 (Q2 2015), and $0.0 (Q1 2015), per Business Quant data.